JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist

612
+19+3.20%

20min DelayMarket Closed Oct 28 15:00 JST

243.51BMarket Cap-771P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

19.80%90.68B

-43.38%314.56B

-16.53%79.53B

-41.56%82.39B

-51.73%76.96B

-52.66%75.69B

-0.80%555.54B

-25.54%95.28B

1.90%140.98B

-1.92%159.41B

Cost of revenue

14.85%34.95B

-29.25%126.58B

-14.73%33.39B

-29.96%32.87B

-36.11%29.89B

-33.93%30.43B

13.87%178.92B

-0.35%39.15B

14.50%46.93B

21.91%46.79B

Gross profit

23.14%55.73B

-50.09%187.98B

-17.79%46.14B

-47.35%49.52B

-58.21%47.06B

-60.24%45.26B

-6.52%376.63B

-36.70%56.13B

-3.40%94.05B

-9.29%112.63B

Operating expense

-39.24%58.83B

19.67%542.84B

145.61%283.26B

-2.59%80.77B

-47.49%81.99B

-2.40%96.82B

32.37%453.6B

33.07%115.33B

-4.37%82.91B

83.95%156.16B

Selling and administrative expenses

-39.43%45.36B

15.06%429.54B

183.83%237.98B

-29.48%57.51B

-54.72%59.15B

-3.10%74.89B

49.88%373.32B

39.62%83.85B

26.73%81.56B

108.62%130.62B

-General and administrative expense

-39.43%45.36B

15.06%429.54B

183.83%237.98B

-29.48%57.51B

-54.72%59.15B

-3.10%74.89B

49.88%373.32B

39.62%83.85B

26.73%81.56B

108.62%130.62B

Research and development costs

-52.87%13.12B

-14.58%112.64B

-30.20%38.99B

-10.47%23.29B

-11.92%22.51B

14.01%27.84B

38.94%131.86B

105.97%55.86B

17.85%26.02B

9.80%25.56B

Other operating expenses

51.54%641M

382.33%8.13B

999.33%6.61B

51.72%663M

20.27%439M

49.47%423M

53.83%1.69B

171.95%601M

-1.35%437M

137.01%365M

Total other operating income

-95.39%292M

-85.98%7.47B

-98.72%320M

-97.20%702M

-71.79%110M

127.22%6.34B

2,113.47%53.26B

3,326.89%24.98B

14,662.35%25.1B

-66.18%390M

Operating profit

93.98%-3.11B

-360.98%-354.86B

-300.52%-237.11B

-380.54%-31.25B

19.75%-34.93B

-452.86%-51.57B

-227.80%-76.98B

-3,051.25%-59.2B

4.52%11.14B

-210.86%-43.53B

Net non-operating interest income (expenses)

-1.01%20.31B

9.24%31.75B

111.12%19.19B

40.57%-17.82B

-45.10%9.86B

-35.88%20.52B

27.86%29.06B

-40.87%9.09B

-629.59%-29.98B

778.76%17.95B

Non-operating interest income

4.78%22.33B

11.81%36.02B

116.66%20.73B

----

-43.11%10.71B

-35.17%21.32B

24.99%32.22B

-40.68%9.57B

----

625.76%18.82B

Non-operating interest expense

153.13%2.03B

35.39%4.28B

221.46%1.54B

-40.57%17.82B

-1.73%851M

-9.40%800M

3.57%3.16B

-37.01%480M

3,753.47%29.98B

57.45%866M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

Income before tax

155.40%17.2B

-574.28%-323.11B

-334.87%-217.92B

-160.40%-49.06B

1.96%-25.08B

-166.62%-31.05B

-157.76%-47.92B

-388.36%-50.11B

-215.47%-18.84B

-161.91%-25.58B

Income tax

-83.78%1.27B

-116.77%-8.19B

-248.07%-20.69B

161.66%899M

-78.61%3.8B

-57.83%7.81B

15.19%48.79B

16.84%13.98B

-113.11%-1.46B

46.41%17.76B

Net income

141.01%15.94B

-225.63%-314.93B

-207.75%-197.23B

-187.41%-49.96B

33.37%-28.87B

-238.34%-38.86B

-338.21%-96.71B

-1,283.07%-64.09B

-434.57%-17.38B

-248.51%-43.33B

Net income continuous operations

141.01%15.94B

-225.63%-314.93B

-207.75%-197.23B

-187.41%-49.96B

33.37%-28.87B

-238.34%-38.86B

-338.21%-96.71B

-1,283.07%-64.09B

-434.57%-17.38B

-248.51%-43.33B

Noncontrolling interests

66.67%-1M

100.18%40M

100.38%31M

100.06%4M

100.04%2M

99.90%-3M

-40.40%-22.2B

-74.19%-8.08B

-30.81%-6.17B

-100.28%-4.94B

Net income attributable to the company

141.01%15.94B

-322.71%-314.97B

-252.19%-197.26B

-345.38%-49.97B

24.78%-28.88B

-224.92%-38.86B

-232.08%-74.51B

-657.09%-56.01B

-213.22%-11.22B

-221.31%-38.39B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

141.01%15.94B

-322.71%-314.97B

-252.19%-197.26B

-345.38%-49.97B

24.78%-28.88B

-224.94%-38.87B

-232.08%-74.51B

-657.09%-56.01B

-213.22%-11.22B

-221.31%-38.39B

Gross dividend payment

Basic earnings per share

141.00%40.11

-322.71%-792.79

-252.18%-496.51

-345.36%-125.77

24.79%-72.68

-224.93%-97.82

-232.09%-187.55

-657.23%-140.98

-213.23%-28.24

-221.30%-96.63

Diluted earnings per share

141.00%40.11

-322.71%-792.79

-252.19%-496.5154

-345.36%-125.77

24.79%-72.68

-224.93%-97.82

-232.09%-187.55

-657.23%-140.98

-213.23%-28.24

-221.30%-96.63

Dividend per share

-25.00%21

-50.00%7

0.00%14

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	19.80%90.68B	-43.38%314.56B	-16.53%79.53B	-41.56%82.39B	-51.73%76.96B	-52.66%75.69B	-0.80%555.54B	-25.54%95.28B	1.90%140.98B	-1.92%159.41B
Cost of revenue	14.85%34.95B	-29.25%126.58B	-14.73%33.39B	-29.96%32.87B	-36.11%29.89B	-33.93%30.43B	13.87%178.92B	-0.35%39.15B	14.50%46.93B	21.91%46.79B
Gross profit	23.14%55.73B	-50.09%187.98B	-17.79%46.14B	-47.35%49.52B	-58.21%47.06B	-60.24%45.26B	-6.52%376.63B	-36.70%56.13B	-3.40%94.05B	-9.29%112.63B
Operating expense	-39.24%58.83B	19.67%542.84B	145.61%283.26B	-2.59%80.77B	-47.49%81.99B	-2.40%96.82B	32.37%453.6B	33.07%115.33B	-4.37%82.91B	83.95%156.16B
Selling and administrative expenses	-39.43%45.36B	15.06%429.54B	183.83%237.98B	-29.48%57.51B	-54.72%59.15B	-3.10%74.89B	49.88%373.32B	39.62%83.85B	26.73%81.56B	108.62%130.62B
-General and administrative expense	-39.43%45.36B	15.06%429.54B	183.83%237.98B	-29.48%57.51B	-54.72%59.15B	-3.10%74.89B	49.88%373.32B	39.62%83.85B	26.73%81.56B	108.62%130.62B
Research and development costs	-52.87%13.12B	-14.58%112.64B	-30.20%38.99B	-10.47%23.29B	-11.92%22.51B	14.01%27.84B	38.94%131.86B	105.97%55.86B	17.85%26.02B	9.80%25.56B
Other operating expenses	51.54%641M	382.33%8.13B	999.33%6.61B	51.72%663M	20.27%439M	49.47%423M	53.83%1.69B	171.95%601M	-1.35%437M	137.01%365M
Total other operating income	-95.39%292M	-85.98%7.47B	-98.72%320M	-97.20%702M	-71.79%110M	127.22%6.34B	2,113.47%53.26B	3,326.89%24.98B	14,662.35%25.1B	-66.18%390M
Operating profit	93.98%-3.11B	-360.98%-354.86B	-300.52%-237.11B	-380.54%-31.25B	19.75%-34.93B	-452.86%-51.57B	-227.80%-76.98B	-3,051.25%-59.2B	4.52%11.14B	-210.86%-43.53B
Net non-operating interest income (expenses)	-1.01%20.31B	9.24%31.75B	111.12%19.19B	40.57%-17.82B	-45.10%9.86B	-35.88%20.52B	27.86%29.06B	-40.87%9.09B	-629.59%-29.98B	778.76%17.95B
Non-operating interest income	4.78%22.33B	11.81%36.02B	116.66%20.73B	----	-43.11%10.71B	-35.17%21.32B	24.99%32.22B	-40.68%9.57B	----	625.76%18.82B
Non-operating interest expense	153.13%2.03B	35.39%4.28B	221.46%1.54B	-40.57%17.82B	-1.73%851M	-9.40%800M	3.57%3.16B	-37.01%480M	3,753.47%29.98B	57.45%866M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax	155.40%17.2B	-574.28%-323.11B	-334.87%-217.92B	-160.40%-49.06B	1.96%-25.08B	-166.62%-31.05B	-157.76%-47.92B	-388.36%-50.11B	-215.47%-18.84B	-161.91%-25.58B
Income tax	-83.78%1.27B	-116.77%-8.19B	-248.07%-20.69B	161.66%899M	-78.61%3.8B	-57.83%7.81B	15.19%48.79B	16.84%13.98B	-113.11%-1.46B	46.41%17.76B
Net income	141.01%15.94B	-225.63%-314.93B	-207.75%-197.23B	-187.41%-49.96B	33.37%-28.87B	-238.34%-38.86B	-338.21%-96.71B	-1,283.07%-64.09B	-434.57%-17.38B	-248.51%-43.33B
Net income continuous operations	141.01%15.94B	-225.63%-314.93B	-207.75%-197.23B	-187.41%-49.96B	33.37%-28.87B	-238.34%-38.86B	-338.21%-96.71B	-1,283.07%-64.09B	-434.57%-17.38B	-248.51%-43.33B
Noncontrolling interests	66.67%-1M	100.18%40M	100.38%31M	100.06%4M	100.04%2M	99.90%-3M	-40.40%-22.2B	-74.19%-8.08B	-30.81%-6.17B	-100.28%-4.94B
Net income attributable to the company	141.01%15.94B	-322.71%-314.97B	-252.19%-197.26B	-345.38%-49.97B	24.78%-28.88B	-224.92%-38.86B	-232.08%-74.51B	-657.09%-56.01B	-213.22%-11.22B	-221.31%-38.39B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	6M	0	0	0	0
Net income attributable to common stockholders	141.01%15.94B	-322.71%-314.97B	-252.19%-197.26B	-345.38%-49.97B	24.78%-28.88B	-224.94%-38.87B	-232.08%-74.51B	-657.09%-56.01B	-213.22%-11.22B	-221.31%-38.39B
Gross dividend payment
Basic earnings per share	141.00%40.11	-322.71%-792.79	-252.18%-496.51	-345.36%-125.77	24.79%-72.68	-224.93%-97.82	-232.09%-187.55	-657.23%-140.98	-213.23%-28.24	-221.30%-96.63
Diluted earnings per share	141.00%40.11	-322.71%-792.79	-252.19%-496.5154	-345.36%-125.77	24.79%-72.68	-224.93%-97.82	-232.09%-187.55	-657.23%-140.98	-213.23%-28.24	-221.30%-96.63
Dividend per share	0	0	0	0	0	0	-25.00%21	-50.00%7	0	0.00%14
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data